Vitor Belfort knows how to get a rise out of the MMA world.
The former UFC Light-Heavyweight champion spoke to MMAFighting.com earlier this week and asked for Chris Weidman to undergo extra drug testing prior to their UFC 173 bout “to make it fair.”
“I don’t believe (Weidman is on steroids), but people give too much importance to the treatment I religiously do with medical support,” said Belfort. “And to make it fair, my opponent should also be tested with blood exams throughout his camp.”
Weidman has never tested positive or been linked to any type of performance enhancing drugs. On the other hand, Belfort tested positive for 4-hydroxytestosterone in 2006 and began the controversial Testosterone Replacement Therapy treatment in 2011.
While Belfort may think he has a solid case for Weidman to undergo extra testing, it’s safe to assume that Weidman will not have to take any supplemental drug tests.
If Belfort wants to stay on TRT he has to play by the commissions rules. If that means extra drug testing then he needs to comply and stop complaining. Weidman should not have to undergo extra testing because of Belfort’s past mistakes.
The Nevada State Athletic Commission has yet to grant Belfort an exemption for his TRT use, but ‘The Phenom’ is not worried about receiving the exemption or not. “(Getting an exemption is) not up to me,” said Belfort. “My job is to train and fight, and that’s what I’m doing.”
As of right now, the cards are stacked against Belfort receiving an exemption for TRT according to one Nevada State Athletic Commission doctor.
With the Weidman-Belfort bout three months away, it can be safe to assume that this won’t be the last we hear about TRT or drug testing in the lead up to fight night.
UFC 173 is scheduled to take place May 24, 2014 from the MGM Grand Garden Arena in Las Vegas, Nevada. The headliner is expected to be a UFC Middleweight Title bout between incumbent champion Chris Weidman (11-0) and Vitor Belfort (24-10). No other bouts have been announced for the card.
For all of your MMA news and science articles, visit SciFighting.com